×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CDNA – caredx, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CDNA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/12
07:20 am
cdna
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
High
Report
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
1/12
07:05 am
cdna
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
High
Report
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
1/7
07:21 am
cdna
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response [Yahoo! Finance]
Low
Report
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response [Yahoo! Finance]
1/7
07:05 am
cdna
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
Low
Report
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
1/6
08:06 am
cdna
CareDx (NASDAQ:CDNA) was downgraded by analysts at Craig Hallum from a "buy" rating to a "hold" rating.
Low
Report
CareDx (NASDAQ:CDNA) was downgraded by analysts at Craig Hallum from a "buy" rating to a "hold" rating.
12/26
04:05 pm
cdna
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/22
10:17 am
cdna
CareDX Has Reached An Inflection Point, But Regulatory Risks Remain (Upgrade) [Seeking Alpha]
Low
Report
CareDX Has Reached An Inflection Point, But Regulatory Risks Remain (Upgrade) [Seeking Alpha]
12/21
01:08 am
cdna
CareDx (NASDAQ:CDNA) was upgraded by analysts at Wall Street Zen fro
Low
Report
CareDx (NASDAQ:CDNA) was upgraded by analysts at Wall Street Zen fro
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/15
04:40 pm
cdna
Form 144 CareDx, Inc. Filed by: Hanna John Walter JR
Low
Report
Form 144 CareDx, Inc. Filed by: Hanna John Walter JR
1/12
07:09 am
cdna
Form 8-K CareDx, Inc. For: Jan 12
High
Report
Form 8-K CareDx, Inc. For: Jan 12
1/7
04:08 pm
cdna
Form 4 CareDx, Inc. For: Jan 06 Filed by: Goldberg Michael
Medium
Report
Form 4 CareDx, Inc. For: Jan 06 Filed by: Goldberg Michael
12/18
05:01 pm
cdna
Form 8-K CareDx, Inc. For: Dec 18
Low
Report
Form 8-K CareDx, Inc. For: Dec 18
12/15
04:02 pm
cdna
Form 8-K CareDx, Inc. For: Dec 15
Low
Report
Form 8-K CareDx, Inc. For: Dec 15
12/5
04:08 pm
cdna
Form 4 CareDx, Inc. For: Dec 04 Filed by: Novack Jeffrey Adam
Low
Report
Form 4 CareDx, Inc. For: Dec 04 Filed by: Novack Jeffrey Adam
12/4
04:40 pm
cdna
Form 144 CareDx, Inc. Filed by: Novack Jeffrey Adam
Medium
Report
Form 144 CareDx, Inc. Filed by: Novack Jeffrey Adam
11/14
11:21 am
cdna
Form SCHEDULE 13G CareDx, Inc. Filed by: BAMCO INC /NY/
Low
Report
Form SCHEDULE 13G CareDx, Inc. Filed by: BAMCO INC /NY/
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/13
CareDx Inc (NASDAQ: CDNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating.
17.3%
4/6 CareDx Supports Launch of International COVID-19 Transplant Registry (C19TxR) 15.5%
5/8 Q1/2019 3/31/2019 EPS 0.050 ZacksConsensus -0.150 ActVsEst 0.200 - Beat 12.9%
1/13 Form 8-K CareDx, Inc. For: Jan 13 10.3%
4/14 CareDx Introduces AlloCell: Cell Therapy Surveillance 7.6%
9/11 CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 7.4%
10/2 Form 4 CareDx, Inc. For: Oct 01 Filed by: COURNOYER CHRISTINE 7.4%
5/1 CareDx Inc (NASDAQ: CDNA) had its price target lowered by analysts at Piper Sandler from $59.00 to $54.00. They now have an "overweight" rating on the stock. 7.4%
3/20 New AJT Publication: AlloSure Monitors First Patient Retransplanted After Anti-PD-L1 Cancer Therapy 7.0%
6/11 CareDx Inc (NASDAQ: CDNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 6.6%
4/6 CareDx Supports Launch of International COVID-19 Transplant Registry (C19TxR) 15.5%
5/8 Q1/2019 3/31/2019 EPS 0.050 ZacksConsensus -0.150 ActVsEst 0.200 - Beat 12.9%
1/13 Form 8-K CareDx, Inc. For: Jan 13 10.3%
4/14 CareDx Introduces AlloCell: Cell Therapy Surveillance 7.6%
9/11 CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 7.4%
10/2 Form 4 CareDx, Inc. For: Oct 01 Filed by: COURNOYER CHRISTINE 7.4%
5/1 CareDx Inc (NASDAQ: CDNA) had its price target lowered by analysts at Piper Sandler from $59.00 to $54.00. They now have an "overweight" rating on the stock. 7.4%
3/20 New AJT Publication: AlloSure Monitors First Patient Retransplanted After Anti-PD-L1 Cancer Therapy 7.0%
6/11 CareDx Inc (NASDAQ: CDNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 6.6%
TOP News Decliners
3/16
Form 4 CareDx, Inc. For: Mar 16 Filed by: Maag Peter
-19.3%
7/15 Form 4/A CareDx, Inc. For: Jun 17 Filed by: Goldberg Michael -12.9%
8/3 INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against CareDx, Inc. -12.4%
10/31 Form 8-K CareDx, Inc. For: Oct 31 -12.0%
11/4 CareDx Advances Patient Care with AlloSure 3.0 -10.7%
3/12 CareDx Joins National Kidney Foundation on World Kidney Day to Support Kidney Transplant Community -10.2%
6/21 Form 4 CareDx, Inc. For: Jun 20 Filed by: Bell Michael Brian -10.0%
8/8 Form 4 CareDx, Inc. For: Aug 06 Filed by: Seeto Reginald -9.0%
7/16 Glancy Prongay & Murray LLP Announces Investigation on Behalf of CareDx, Inc. Investors (CDNA) -8.4%
10/16 CareDx Inc (NASDAQ: CDNA) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -8.3%
7/15 Form 4/A CareDx, Inc. For: Jun 17 Filed by: Goldberg Michael -12.9%
8/3 INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against CareDx, Inc. -12.4%
10/31 Form 8-K CareDx, Inc. For: Oct 31 -12.0%
11/4 CareDx Advances Patient Care with AlloSure 3.0 -10.7%
3/12 CareDx Joins National Kidney Foundation on World Kidney Day to Support Kidney Transplant Community -10.2%
6/21 Form 4 CareDx, Inc. For: Jun 20 Filed by: Bell Michael Brian -10.0%
8/8 Form 4 CareDx, Inc. For: Aug 06 Filed by: Seeto Reginald -9.0%
7/16 Glancy Prongay & Murray LLP Announces Investigation on Behalf of CareDx, Inc. Investors (CDNA) -8.4%
10/16 CareDx Inc (NASDAQ: CDNA) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -8.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: